10th Jun 2020 18:02
OKYO Pharma Ltd - London-based pharmaceutical company - Appoints John Brancaccio as a non-executive director. Gregor MacRae simultaneously standing down as a director. Board changes are with immediate effect. Brancaccio, prior to his retirement in 2017, was chief financial officer of Accelerated Technologies Inc.
Current stock price: 4.95 pence
By Tapan Panchal; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
OKYO.L